Vivos Therapeutics, Inc IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Vivos Therapeutics, Inc | VVOS - NASDAQ |
$5.00-$7.00 | $6.00 | $7.07 | 3.33 million ADSs | 12/11/2020 |
| Roth Capital | ||||||
Co-Manager(s): Craig-Hallum Capital, National Securities | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-11-27 | ||||||
Vivos Therapeutics, Inc Quote & Chart - Click for current quote - VVOS
IPO Boutique aggregates information on public companies and private companies, such as "VVOS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Vivos Therapeutics, Inc (adapted from Vivos Therapeutics, Inc prospectus):
They are a revenue stage medical technology company focused on the development and commercialization of a highly differentiated technology offering a clinically effective non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA).
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a revenue stage medical technology company focused on the development and commercialization of a highly differentiated technology offering a clinically effective non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA).
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "VVOS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.